GWAS have shown a great coincidence of MS-risk alleles in the IL-6-, IL-12-, and IL-23-induced STAT3/4-pathways [2,3,4], suggesting a risk allele-induced change in the activity of these pathways. This evidence concerns the gene IL6 and myeloid sarcoma.